FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1137367000: Imdevimab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4525774016 Imdevimab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4525775015 Imdevimab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imdevimab (substance) Is a Monoclonal antibody true Inferred relationship Some
Imdevimab (substance) Is a Substance with antiviral mechanism of action (substance) true Inferred relationship Some
Imdevimab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiviral (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Imdevimab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imdevimab (substance) Inferred relationship Some 1
Product containing only imdevimab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imdevimab (substance) Inferred relationship Some 1
Product containing imdevimab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imdevimab (substance) Inferred relationship Some 1
Product containing only imdevimab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imdevimab (substance) Inferred relationship Some 1
Imdevimab 120 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Imdevimab (substance) Inferred relationship Some 1
Imdevimab 120 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Imdevimab (substance) Inferred relationship Some 1
Casirivimab and imdevimab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imdevimab (substance) Inferred relationship Some 2
Casirivimab- and imdevimab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imdevimab (substance) Inferred relationship Some 2
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imdevimab (substance) Inferred relationship Some 2
Product containing casirivimab and imdevimab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imdevimab (substance) Inferred relationship Some 2
Product containing precisely casirivimab 60 milligram/1 milliliter and imdevimab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Imdevimab (substance) Inferred relationship Some 2
Product containing precisely casirivimab 60 milligram/1 milliliter and imdevimab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Imdevimab (substance) Inferred relationship Some 2
Administration of imdevimab Direct substance True Imdevimab (substance) Inferred relationship Some 1
Administration of casirivimab and imdevimab Direct substance True Imdevimab (substance) Inferred relationship Some 2
Adverse reaction to imdevimab (disorder) Causative agent (attribute) True Imdevimab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start